Security key
82835W108
ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SPRY)
CUSIP: 82835W108
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 99,255,583
- Total 13F shares
- 83,632,743
- Share change
- -894,930
- Total reported value
- $840,434,931
- Put/Call ratio
- 57%
- Price per share
- $10.05
- Number of holders
- 187
- Value change
- -$93,311,095
- Number of buys
- 111
- Number of sells
- 85
Report period
Q3 2025
Institutions
187
Top holders
10
SPRY full security history
Newer quarter: Q4 2025
Previous quarter: Q2 2025
ARS Pharmaceuticals, Inc. SEC filings
ARS Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 82835W108
Recent filing periods:
Top shareholders of SPRY - ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13F
13D/G
3/4/5
|
Company · Director, 10%+ Owner |
11%
from 13D/G
|
10,860,977
|
$189,524,049 | — | 30 Jun 2025 | |
| James E. Flynn |
3/4/5
13D/G
|
10%+ Owner · Deerfield Management Company, L.P. |
7.8%
from 13D/G
|
9,774,508
|
$180,437,416 | -$13,663,151 | 27 Jun 2025 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
9.8%
|
9,724,508
|
$169,692,665 | — | 30 Jun 2025 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
8.4%
|
8,288,510
|
$144,634,500 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
|
Company |
4.5%
|
4,423,464
|
$77,189,447 | — | 30 Jun 2025 | |
| SR ONE CAPITAL MANAGEMENT, LP |
13F
|
Company |
4%
|
4,012,903
|
$70,025,157 | — | 30 Jun 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
3.9%
|
3,825,793
|
$66,760,088 | — | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.3%
|
3,262,673
|
$56,933,643 | — | 30 Jun 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2.3%
|
2,242,176
|
$39,125,971 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
2.2%
|
2,194,493
|
$38,293,903 | — | 30 Jun 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.8%
|
1,828,755
|
$31,911,774 | — | 30 Jun 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.7%
|
1,728,000
|
$30,153,600 | — | 30 Jun 2025 | |
| Southpoint Capital Advisors LP |
13F
|
Company |
1.7%
|
1,709,069
|
$29,823,254 | — | 30 Jun 2025 | |
| FMR LLC |
13F
|
Company |
1.6%
|
1,567,010
|
$27,344,325 | — | 30 Jun 2025 | |
| Aberdeen Group plc |
13F
|
Company |
1.5%
|
1,502,575
|
$26,219,934 | — | 30 Jun 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.5%
|
1,464,312
|
$25,552,244 | — | 30 Jun 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1.4%
|
1,433,187
|
$25,009,114 | — | 30 Jun 2025 | |
| Octagon Capital Advisors LP |
13F
|
Company |
1.4%
|
1,350,000
|
$23,557,500 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.4%
|
1,342,387
|
$23,427,118 | — | 30 Jun 2025 | |
| MPM BioImpact LLC |
13F
|
Company |
1.3%
|
1,303,399
|
$22,744,313 | — | 30 Jun 2025 | |
| Rubric Capital Management LP |
13F
|
Company |
1.3%
|
1,294,878
|
$22,595,621 | — | 30 Jun 2025 | |
| Cormorant Asset Management, LP |
13F
|
Company |
1.1%
|
1,100,000
|
$19,195,000 | — | 30 Jun 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.88%
|
878,157
|
$15,323,840 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.87%
|
866,935
|
$15,128,016 | — | 30 Jun 2025 | |
| Nextech Invest, Ltd. |
13F
|
Company |
0.75%
|
741,729
|
$12,943,171 | — | 30 Jun 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.68%
|
673,370
|
$11,750,307 | — | 30 Jun 2025 | |
| NEXT CENTURY GROWTH INVESTORS LLC |
13F
|
Company |
0.63%
|
622,823
|
$10,868,261 | — | 30 Jun 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.63%
|
622,235
|
$10,858,001 | — | 30 Jun 2025 | |
| Janney Montgomery Scott LLC |
13F
|
Company |
0.6%
|
591,425
|
$10,320,000 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.49%
|
485,014
|
$8,463,493 | — | 30 Jun 2025 | |
| ARDSLEY ADVISORY PARTNERS LP |
13F
|
Company |
0.48%
|
475,000
|
$8,288,750 | — | 30 Jun 2025 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.47%
|
464,030
|
$8,097,324 | — | 30 Jun 2025 | |
| PEREGRINE CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.46%
|
456,979
|
$7,974,284 | — | 30 Jun 2025 | |
| First Turn Management, LLC |
13F
|
Company |
0.46%
|
455,953
|
$7,956,380 | — | 30 Jun 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.45%
|
442,202
|
$7,716,425 | — | 30 Jun 2025 | |
| Lisanti Capital Growth, LLC |
13F
|
Company |
0.42%
|
420,075
|
$7,330,309 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.39%
|
383,616
|
$6,694,106 | — | 30 Jun 2025 | |
| WEXFORD CAPITAL LP |
13F
|
Company |
0.39%
|
382,555
|
$6,675,580 | — | 30 Jun 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.35%
|
345,055
|
$6,021,210 | — | 30 Jun 2025 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.34%
|
340,119
|
$5,935,076 | — | 30 Jun 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.33%
|
329,073
|
$5,742,324 | — | 30 Jun 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.33%
|
325,645
|
$5,682,505 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.33%
|
325,352
|
$5,677,391 | — | 30 Jun 2025 | |
| Neuberger Berman Group LLC |
13F
|
Company |
0.33%
|
324,877
|
$5,669,103 | — | 30 Jun 2025 | |
| K2 PRINCIPAL FUND, L.P. |
13F
|
Company |
0.32%
|
317,126
|
$5,533,849 | — | 30 Jun 2025 | |
| Woodline Partners LP |
13F
|
Company |
0.3%
|
300,419
|
$5,242,312 | — | 30 Jun 2025 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
0.3%
|
294,111
|
$5,132,237 | — | 30 Jun 2025 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.29%
|
290,092
|
$5,062,105 | — | 30 Jun 2025 | |
| LEVIN CAPITAL STRATEGIES, L.P. |
13F
|
Company |
0.29%
|
289,147
|
$5,045,615 | — | 30 Jun 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.26%
|
256,966
|
$4,484,057 | — | 30 Jun 2025 |
Institutional Holders of ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SPRY) as of Q3 2025
As of 30 Sep 2025,
ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SPRY) was held by
187 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
83,632,743 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., ORBIMED ADVISORS LLC, DEERFIELD MANAGEMENT COMPANY, L.P., BlackRock, Inc., Rubric Capital Management LP, SR One Capital Management, LP, VANGUARD GROUP INC, Aberdeen Group plc, STATE STREET CORP, and ALLIANCEBERNSTEIN L.P..
This page lists
187
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
185
Q3 2025 holders
187
Holder diff
2
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.